TTechnology Read More Crick spin‑out ALTx will target cancer cell immortalityFebruary 11, 2026  Founded in late 2024, ALTx Therapeutics has come out of stealth mode with plans to develop therapies…
SScience Read More Reprogrammed neutrophils promote tumor growthFebruary 5, 2026 Predicting tumor progression is one of the major challenges in oncology. Scientists at the University of Geneva (UNIGE)…
SScience Read More Study shows DHPS enzyme controls macrophage maturation across multiple organsJanuary 22, 2026 A new study led by researchers at the Johns Hopkins Kimmel Cancer Center, its Bloomberg~Kimmel Institute for Cancer Immunotherapy and the Johns…
TTechnology Read More Web-based cytometry atlas reveals immune signatures across pancreatic cancer treatmentsJanuary 17, 2026 Oncologists have achieved some immune system responses in patients with pancreatic cancers using various combinations of vaccines and…
HHealthcare Read More JPM26: J&J reveals oncology strategyJanuary 15, 2026 CEO Joaquin Duato presented a strong outlook for Johnson & Johnson’s (J&J) revenue growth in 2026, with particular…
HHealth Read More Novel immunotherapy targeting pancreatic cancer shows promising results in phase 1/2 trialJanuary 14, 2026 A recent publication in Nature Medicine describes a novel immunotherapy targeting pancreatic cancer that has shown promising results in a…
HHealth Read More Durvalumab extends survival in small cell lung cancer but raises cost concernsJanuary 10, 2026 A new study suggests that the immune checkpoint inhibitor, durvalumab, may offer new treatment options for patients living…
BBusiness Read More Novartis to add radioligand therapy manufacturing facility in Winter Park, Florida, fourth in US to serve patients and advance $23 billion investmentJanuary 9, 2026 New 35,000-square-foot facility in Winter Park will expand RLT manufacturing footprint to optimize delivery for patients across southeastern…
HHealth Read More Clonal hematopoiesis linked to increased heart disease risk in cancer patients receiving treatmentJanuary 8, 2026 About 1 in 5 patients with cancer who undergo genetic testing are incidentally found to have mutations in…
HHealth Read More Advanced AI provides accurate guidance for prostate cancer patientsJanuary 8, 2026 Mayo Clinic researchers have developed and evaluated MedEduChat, an electronic health record (EHR) that works with a large language model to provide accurate, patient-specific prostate cancer education. The…
HHealth Read More Artificial intelligence unlocks new frontiers in RNA drug designDecember 31, 2025 In the realm of modern medicine, RNA-based therapies have emerged as a promising avenue, with significant advancements in…
HHealth Read More Busting Prostate Cancer Myths: Facts Malaysian Men Should Know For Early Detection, Better OutcomesDecember 22, 2025 KUALA LUMPUR, Dec 22 — Prostate cancer remains one of the most misunderstood cancers among Malaysian men, despite…